Bronte Capital Management Pty Ltd. Grows Stock Holdings in iShares Biotechnology ETF $IBB

Bronte Capital Management Pty Ltd. increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 12.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 295,346 shares of the financial services provider’s stock after purchasing an additional 32,947 shares during the quarter. iShares Biotechnology ETF accounts for 0.0% of Bronte Capital Management Pty Ltd.’s portfolio, making the stock its 19th largest position. Bronte Capital Management Pty Ltd. owned about 0.72% of iShares Biotechnology ETF worth $37,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the stock. Citigroup Inc. lifted its holdings in shares of iShares Biotechnology ETF by 27.0% during the 2nd quarter. Citigroup Inc. now owns 4,073,967 shares of the financial services provider’s stock valued at $515,398,000 after buying an additional 865,823 shares during the period. Knott David M Jr bought a new position in iShares Biotechnology ETF in the second quarter valued at about $253,000. Financial Gravity Companies Inc. bought a new position in iShares Biotechnology ETF in the second quarter valued at about $29,000. Kingsview Wealth Management LLC boosted its position in iShares Biotechnology ETF by 4.2% in the second quarter. Kingsview Wealth Management LLC now owns 3,381 shares of the financial services provider’s stock worth $428,000 after purchasing an additional 135 shares during the last quarter. Finally, Citizens Financial Group Inc. RI grew its stake in shares of iShares Biotechnology ETF by 7.7% during the 2nd quarter. Citizens Financial Group Inc. RI now owns 2,949 shares of the financial services provider’s stock valued at $373,000 after purchasing an additional 211 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.8%

NASDAQ IBB opened at $165.22 on Thursday. The company has a 50-day moving average price of $152.42 and a 200-day moving average price of $137.87. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $167.15.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were issued a dividend of $0.0828 per share. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.